Israel Chemicals Ltd. (NYSE:ICL) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Monday. The brokerage currently has a $4.25 price objective on the stock. Zacks Investment Research’s price objective indicates a potential upside of 8.97% from the company’s previous close.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Shares of Israel Chemicals (NYSE:ICL) opened at 3.90 on Monday. The company’s 50 day moving average is $3.74 and its 200-day moving average is $3.99. The firm has a market capitalization of $4.96 billion, a price-to-earnings ratio of 12.30 and a beta of 1.14. Israel Chemicals has a one year low of $3.52 and a one year high of $5.23.

Large investors have recently bought and sold shares of the company. Jarislowsky Fraser Ltd raised its stake in Israel Chemicals by 3.1% in the second quarter. Jarislowsky Fraser Ltd now owns 29,084 shares of the company’s stock worth $113,000 after buying an additional 887 shares in the last quarter. Alliancebernstein L.P. raised its stake in Israel Chemicals by 1.6% in the second quarter. Alliancebernstein L.P. now owns 496,495 shares of the company’s stock worth $1,936,000 after buying an additional 7,874 shares in the last quarter. Nikko Asset Management Americas Inc. raised its stake in Israel Chemicals by 1.2% in the second quarter. Nikko Asset Management Americas Inc. now owns 714,283 shares of the company’s stock worth $2,807,000 after buying an additional 8,800 shares in the last quarter. Public Sector Pension Investment Board raised its stake in Israel Chemicals by 19.0% in the second quarter. Public Sector Pension Investment Board now owns 96,656 shares of the company’s stock worth $374,000 after buying an additional 15,400 shares in the last quarter. Finally, Foyston Gordon & Payne Inc raised its stake in Israel Chemicals by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock worth $7,834,000 after buying an additional 16,631 shares in the last quarter. 6.51% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This article was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and republished in violation of US and international trademark & copyright law. The correct version of this article can be read at https://www.thecerbatgem.com/2016/11/23/israel-chemicals-ltd-icl-rating-increased-to-buy-at-zacks-investment-research.html.

5 Day Chart for NYSE:ICL

Receive News & Stock Ratings for Israel Chemicals Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Ltd. and related stocks with our FREE daily email newsletter.